Search

Financial results - ACE PHARMA INTERNATIONAL S.R.L.

0.00
Financial Summary - Ace Pharma International S.r.l.
Unique identification code: 40488882
Registration number: J40/825/2019
Nace: 7022
Sales - Ron
13.942
Net Profit - Ron
9.280
Employees
Open Account
Company Ace Pharma International S.r.l. with Fiscal Code 40488882 recorded a turnover of 2024 of 13.942, with a net profit of 9.280 and having an average number of employees of - . The company operates in the field of Activitati de consultanta pentru afaceri si management having the NACE code 7022.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Ace Pharma International S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - 51.288 0 30.583 50.782 105.117 13.942
Total Income - EUR - - - - 51.288 0 30.583 50.784 105.118 13.958
Total Expenses - EUR - - - - 2.845 2.567 1.781 3.660 9.430 3.950
Gross Profit/Loss - EUR - - - - 48.443 -2.567 28.801 47.124 95.688 10.007
Net Profit/Loss - EUR - - - - 47.126 -2.567 27.902 45.909 94.658 9.280
Employees - - - - 1 1 1 1 1 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -86.7%, from 105.117 euro in the year 2023, to 13.942 euro in 2024. The Net Profit decreased by -84.849 euro, from 94.658 euro in 2023, to 9.280 in the last year.
Sales - Ron
Net Profit - Ron
Employees
See Company Data

Check the financial reports for the company - Ace Pharma International S.r.l.

Rating financiar

Financial Rating -
ACE PHARMA INTERNATIONAL S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Ace Pharma International S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Ace Pharma International S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Ace Pharma International S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Ace Pharma International S.r.l. - CUI 40488882

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - 17 0 0 0 0 512
Current Assets - - - - 47.394 -7 26.164 46.253 97.567 8.433
Inventories - - - - 0 0 0 0 0 0
Receivables - - - - 31.279 0 26.003 39.214 89.291 3.214
Cash - - - - 16.116 -7 161 7.039 8.276 5.219
Shareholders Funds - - - - 47.168 -2.518 25.440 45.958 94.707 9.329
Social Capital - - - - 42 41 0 0 0 0
Debts - - - - 319 2.517 724 295 2.861 -384
Income in Advance - - - - 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "7022 - 7022"
CAEN Financial Year 7022
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 8.433 euro in 2024 which includes Inventories of 0 euro, Receivables of 3.214 euro and cash availability of 5.219 euro.
The company's Equity was valued at 9.329 euro, while total Liabilities amounted to -384 euro. Equity decreased by -84.849 euro, from 94.707 euro in 2023, to 9.329 in 2024.
Monitors the Company

Risk Reports Prices

Reviews - Ace Pharma International S.r.l.

Comments - Ace Pharma International S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.